SCICLONE PHARMACEUTICALS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012
Net revenues:
Product sales, net
Promotion services
Total net revenues
Operating expenses:
Cost of product sales
Sales and marketing
Amortization of acquired intangible assets, related to sales and marketing
Research and development
General and administrative
Restructuring charges
Estimated SEC and DOJ investigation loss (Note 19)
Intangible asset impairment (Note 7)
Contingent consideration (Note 4 & 9)
Change in fair value of contingent consideration (Notes 3 & 8)
Amortization of acquired intangible assets
Change in fair value of contingent consideration (Note 3)
SEC settlement expense (Note 15)
Total operating expenses

Income from operations
Non-operating income (expense):
Interest and investment income
Interest and investment expense
Other income (expense), net
Income before provision for income tax
Provision for income tax
Net income
Basic net income per share
Diluted net income per share
Weighted average shares used in computing:
Basic net income per share
Diluted net income per share

Comments